Search Results - Stella, Peter

  • Showing 1 - 14 results of 14
Refine Results
  1. 1
    Pharmaceutical pricing, cost containment and new treatments for rare diseases in children

    Pharmaceutical pricing, cost containment and new treatments for rare diseases in children by Stella, Peter, Gold-von Simson, Gabrielle

    Published 2014
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Prediction of Resuscitation for Pediatric Sepsis from Data Available at Triage

    Prediction of Resuscitation for Pediatric Sepsis from Data Available at Triage by Stella, Peter, Haines, Elizabeth, Aphinyanaphongs, Yindalon

    Published 2022
    Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Insulin Glargine 300 U/mL and Insulin Glulisine Treatment in Patients with Type 2 Diabetes: A Non-Interventional Study of Effectiveness in Routine Clinical Practice

    Insulin Glargine 300 U/mL and Insulin Glulisine Treatment in Patients with Type 2 Diabetes: A Non-Interventional Study of Effectiveness in Routine Clinical Practice by Hidvégi, Tibor, Balogh, Zoltán, Vass, Viktor, Kovács, Gábor, Stella, Péter

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    Impact of Switching from Twice-Daily Basal Insulin to Once-Daily Insulin Glargine 300 U/mL in People with Type 1 Diabetes on Basal–Bolus Insulin: Phase 4 OPTIMIZE Study

    Impact of Switching from Twice-Daily Basal Insulin to Once-Daily Insulin Glargine 300 U/mL in People with Type 1 Diabetes on Basal–Bolus Insulin: Phase 4 OPTIMIZE Study by Mathieu, Chantal, Weisnagel, S. John, Stella, Peter, Bruhwyler, Jacques, Alexandre, Kathy

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    Association of Patient Profile with Glycemic Control and Hypoglycemia with Insulin Glargine 300 U/mL in Type 2 Diabetes: A Post Hoc Patient-Level Meta-Analysis

    Association of Patient Profile with Glycemic Control and Hypoglycemia with Insulin Glargine 300 U/mL in Type 2 Diabetes: A Post Hoc Patient-Level Meta-Analysis by Twigg, Stephen M., Escalada, Javier, Stella, Peter, Merino-Trigo, Ana, Lavalle-Gonzalez, Fernando J., Cariou, Bertrand, Meneghini, Luigi F.

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    Validation of parsimonious prognostic models for patients infected with COVID-19

    Validation of parsimonious prognostic models for patients infected with COVID-19 by Harish, Keerthi, Zhang, Ben, Stella, Peter, Hauck, Kevin, Moussa, Marwa M, Adler, Nicole M, Horwitz, Leora I, Aphinyanaphongs, Yindalon

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    Glycaemic control and hypoglycaemia burden in patients with type 2 diabetes initiating basal insulin in Europe and the USA

    Glycaemic control and hypoglycaemia burden in patients with type 2 diabetes initiating basal insulin in Europe and the USA by Mauricio, Dídac, Meneghini, Luigi, Seufert, Jochen, Liao, Laura, Wang, Hongwei, Tong, Liyue, Cali, Anna, Stella, Peter, Carita, Paulo, Khunti, Kamlesh

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    Treatment Dosing Patterns and Clinical Outcomes for Patients with Type 2 Diabetes Starting or Switching to Treatment with Insulin Glargine (300 Units per Milliliter) in a Real-World Setting: A Retrospective Observational Study

    Treatment Dosing Patterns and Clinical Outcomes for Patients with Type 2 Diabetes Starting or Switching to Treatment with Insulin Glargine (300 Units per Milliliter) in a Real-Worl... by Gupta, Shaloo, Wang, Hongwei, Skolnik, Neil, Tong, Liyue, Liebert, Ryan M., Lee, Lulu K., Stella, Peter, Cali, Anna, Preblick, Ronald

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    The effect of concomitant DPPIVi use on glycaemic control and hypoglycaemia with insulin glargine 300 U/mL (Gla-300) versus insulin glargine 100 U/mL (Gla-100) in people with type 2 diabetes: A patient-level meta-analysis of EDITION 2 and 3

    The effect of concomitant DPPIVi use on glycaemic control and hypoglycaemia with insulin glargine 300 U/mL (Gla-300) versus insulin glargine 100 U/mL (Gla-100) in people with type... by Yale, Jean-François, Pettus, Jeremy Hodson, Brito-Sanfiel, Miguel, Lavalle-Gonzalez, Fernando, Merino-Trigo, Ana, Stella, Peter, Chevalier, Soazig, Buzzetti, Raffaella

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    Efficacy and Safety of iGlarLixi, Fixed-Ratio Combination of Insulin Glargine and Lixisenatide, Compared with Basal-Bolus Regimen in Patients with Type 2 Diabetes: Propensity Score Matched Analysis

    Efficacy and Safety of iGlarLixi, Fixed-Ratio Combination of Insulin Glargine and Lixisenatide, Compared with Basal-Bolus Regimen in Patients with Type 2 Diabetes: Propensity Score... by Tabák, Ádám G., Anderson, John, Aschner, Pablo, Liu, Minzhi, Saremi, Aramesh, Stella, Peter, Tinahones, Francisco J., Wysham, Carol, Meier, Juris J.

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  11. 11
    Glycaemic control and hypoglycaemia in people with type 2 diabetes switching from twice‐daily basal insulin to once‐daily insulin glargine 300 U/mL or insulin glargine 100 U/mL (EDITION 1 and EDITION 2 subgroup analysis)

    Glycaemic control and hypoglycaemia in people with type 2 diabetes switching from twice‐daily basal insulin to once‐daily insulin glargine 300 U/mL or insulin glargine 100 U/mL (ED... by Roussel, Ronan, d'Emden, Michael C., Fisher, Miles, Ampudia‐Blasco, F. Javier, Stella, Peter, Bizet, Florence, Cali, Anna M. G., Wysham, Carol H.

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  12. 12
    The Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) study in type 2 diabetes: Achieving HbA1c targets with basal insulin in a real‐world setting

    The Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) study in type 2 diabetes: Achieving HbA1c targets with basal insulin in a real‐world setting by Meneghini, Luigi F., Mauricio, Didac, Orsi, Emanuela, Lalic, Nebojsa M., Cali, Anna M.G., Westerbacka, Jukka, Stella, Peter, Candelas, DEA, Christophe, Pilorget, Valerie, Perfetti, Riccardo, Khunti, Kamlesh

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  13. 13
    Urinary NGAL Marks Cystic Disease in HIV-Associated Nephropathy

    Urinary NGAL Marks Cystic Disease in HIV-Associated Nephropathy by Paragas, Neal, Nickolas, Thomas L., Wyatt, Christina, Forster, Catherine S., Sise, Meghan, Morgello, Susan, Jagla, Bernd, Buchen, Charles, Stella, Peter, Sanna-Cherchi, Simone, Carnevali, Maria Luisa, Mattei, Silvia, Bovino, Achiropita, Argentiero, Lucia, Magnano, Andrea, Devarajan, Prasad, Schmidt-Ott, Kai M., Allegri, Landino, Klotman, Paul, D'Agati, Vivette, Gharavi, Ali G., Barasch, Jonathan

    Published 2009
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  14. 14
    A validated, real-time prediction model for favorable outcomes in hospitalized COVID-19 patients

    A validated, real-time prediction model for favorable outcomes in hospitalized COVID-19 patients by Razavian, Narges, Major, Vincent J., Sudarshan, Mukund, Burk-Rafel, Jesse, Stella, Peter, Randhawa, Hardev, Bilaloglu, Seda, Chen, Ji, Nguy, Vuthy, Wang, Walter, Zhang, Hao, Reinstein, Ilan, Kudlowitz, David, Zenger, Cameron, Cao, Meng, Zhang, Ruina, Dogra, Siddhant, Harish, Keerthi B., Bosworth, Brian, Francois, Fritz, Horwitz, Leora I., Ranganath, Rajesh, Austrian, Jonathan, Aphinyanaphongs, Yindalon

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: